Detalles de la búsqueda
1.
The experience of point-of-care testing for influenza in Scotland in 2017/18 and 2018/19 - no gain without pain.
Euro Surveill
; 25(44)2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33153519
2.
Tumour cell responses to MEK1/2 inhibitors: acquired resistance and pathway remodelling.
Biochem Soc Trans
; 40(1): 73-8, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22260668
3.
Dual direction CRISPR transcriptional regulation screening uncovers gene networks driving drug resistance.
Sci Rep
; 7(1): 17693, 2017 12 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-29255251
4.
Identification of approved and investigational drugs that inhibit hypoxia-inducible factor-1 signaling.
Oncotarget
; 7(7): 8172-83, 2016 Feb 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-26882567
5.
Increasing the performance of pooled CRISPR-Cas9 drop-out screening.
Sci Rep
; 6: 31782, 2016 08 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-27545104
6.
A correction to the research article titled: "Amplification of the driving oncogene, KRAS or BRAF, underpins acquired resistance to MEK1/2 inhibitors in colorectal cancer cells" by A. S. Little, K. Balmanno, M. J. Sale, S. Newman, J. R. Dry, M. Hampson, P. A. W. Edwards, P. D. Smith, S. J. Cook.
Sci Signal
; 4(170): er2, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21674991
7.
Amplification of the driving oncogene, KRAS or BRAF, underpins acquired resistance to MEK1/2 inhibitors in colorectal cancer cells.
Sci Signal
; 4(166): ra17, 2011 Mar 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-21447798
Resultados
1 -
7
de 7
1
Próxima >
>>